Nolan E, Lindeman GJ. and J. E. Visvader. Deciphering Breast Cancer: From Biology to the Clinic. CELL. 2023;186(8):1708-28.
Sukocheva OA, Lukina E, Friedemann M, Menschikowski M, Hagelgans A, Gjumrakch Aliev. The crucial role of epigenetic regulation in breast cancer Anti-Estrogen resistance: current findings and future perspectives. Sem Cancer Biol. 2022;82:35–59.
Laws A, Punglia RS. Endocrine therapy for primary and secondary prevention after diagnosis of High-Risk breast lesions or preinvasive breast cancer. J Clin Oncol. 2023;41(17):3092–99.
Article CAS PubMed Google Scholar
Guo H, Tan YQ, Huang X, Zhang S, Basappa B, Zhu T, Pandey V, Peter E. Lobie. Small molecule Inhibition of TFF3 overcomes Tamoxifen resistance and enhances taxane efficacy in ER + Mammary carcinoma. Cancer Lett. 2023;579:216443.
Article CAS PubMed Google Scholar
Szostakowska Małgorzata, Trębińska-Stryjewska A, Grzybowska EA, Fabisiewicz A. Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals. Breast Cancer Res Treat. 2019;173(3):489–97.
He H, Sinha I, Haldosen RFL-A, Zhao FYC, Dahlman-Wright K. C-Jun/AP-1 Overexpression Reprograms ERα Signaling Related to Tamoxifen Response in ERα-positive Breast Cancer. ONCOGENE. 2018;37(19):2586 – 600.
de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403.
Qin Q, Yu R, Eriksson JE,. Cancer Lett. 2024;591:216859.
Article CAS PubMed Google Scholar
Hu D, Li Z, Zheng B, Lin X, Pan Y, Gong P, Zhuo W, Hu Y, Chen C, Chen L. Jichun zhou, and Linbo wang. Cancer-Associated fibroblasts in breast cancer: challenges and opportunities. Cancer Commun. 2022;42(5):401–34.
Namee N, Mc, Lorraine OD. Extracellular vesicles and Anti-Cancer drug resistance. Biochimica et biophysica ACTA-reviews on cancer. 2018;1870(2):123–36.
Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S. Extracellular Vesicles-Mediated intercellular communication: roles in the tumor microenvironment and Anti-Cancer drug resistance. Mol Cancer. 2019;18(1):55.
Article PubMed PubMed Central Google Scholar
Gao Y, Li X, Zeng C, Liu C, Hao Q, Li W, Zhang K, Zhang W, Wang S, Zhao H, Li DFM, Zhang Y. Wei zhang, and Cun zhang. CD63 + cancer-Associated fibroblasts confer Tamoxifen resistance to breast cancer cells through Exosomal miR‐22. Adv Sci. 2020;7:21.
Sun J, Du R, Li X, Liu C, Wang D, He X, Li G, Zhang K, Wang S, Hao Q, Zhang Y, Li M, Gao Y, Zhang C. CD63(+) cancer-Associated fibroblasts confer CDK4/6 inhibitor resistance to breast cancer cells by Exosomal miR-20. Cancer Lett. 2024;588:216747.
Article CAS PubMed Google Scholar
Slack FJ, Arul M. Chinnaiyan. The Role of Non-Coding RNAs in Oncology. CELL. 2019;179(5):1033-55.
Crudele F, Bianchi N, Reali E, Galasso M, Agnoletto C, Stefano Volinia. The network of Non-Coding RNAs and their molecular targets in breast cancer. Mol Cancer. 2020;19(1):61.
Article PubMed PubMed Central Google Scholar
Wu S, Lu J, Zhu H, Wu F, Mo Y, Xie L, Song C, Liu L, Xie X, Li Y. Huan lin, and Hailin tang. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in Triple-Negative breast cancer. Cancer Lett. 2024;581:216508.
Article CAS PubMed Google Scholar
Zhang Y, Tan Y, Yuan J, Tang H, Zhang H, Tang Y, Xie Y, Wu L, Xie J, Xiao X, Li Y, Yanan Kong. CircLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Cancer Lett. 2024;592:216907.
Article CAS PubMed Google Scholar
Jiang M, Huang O, Xie Z, Wu S, Zhang X, Shen A, Liu H, Chen X, Wu J, Lou Y, Mao Y. Kan sun, Shudong hu, Meiyu geng, and Kunwei shen. A novel long Non-Coding RNA-ARA: adriamycin resistance associated. Biochem Pharmacol. 2014;87(2):254–83.
Article CAS PubMed Google Scholar
Yan Z, Sheng Z, Zheng Y, Feng R, Shi QXL, Li H, Yin C, Luo H, Hao C, Wang W, Zhang B. Cancer-Associated Fibroblast-Derived Exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7. Cell Death Dis. 2021;12(12):1120.
Article CAS PubMed PubMed Central Google Scholar
Shang C, Li Y, He T, Liao Y, Du Q, Wang P, Qiao J, Guo H. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer. J Adv Res. 2022;37:169–84.
Article CAS PubMed Google Scholar
Thomson DW, Marcel E. Dinger. Endogenous MicroRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–83.
Article CAS PubMed Google Scholar
Qiao X, Ding Y, Altawil A, Yin Y, Wang Q, Wang W, Kang J. Roles of noncoding RNAs in chronic obstructive pulmonary disease. J Translational Intern Med. 2023;11(2):106–10.
Zhou Y, Shao Y, Hu W, Zhang J, Shi Y, Kong X, Jiang J. A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3. Cell Death Differ. 2023;30(1):111–24.
Article CAS PubMed Google Scholar
Wang K, Zhou BLL-Y, Liu F, Zhou Q-Y, Liu C-Y, Fan Y-Y, Pei-Feng, Li. CARL LncRNA inhibits Anoxia-Induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nature Communications. 2014;5(1):3596.
Haagenson KK. The role of MAP kinases and MAP kinase Phosphatase-1 in resistance to breast cancer treatment. Cancer Metastasis Rev. 2010;29(1):143–49.
Article CAS PubMed PubMed Central Google Scholar
García-Becerra Rocío, Santos N, Díaz L. Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, MiRNAs and genetically based resistance. Int J Mol Sci. 2013;14(1):108–45.
Chen Y, Zhu S, Liu T, Zhang S, Lu J, Fan W, Lin L, Xiang T, Yang J, Zhao X, Xi Y, Ma Y, Cheng G, Lin D, Wu C. Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell. 2023;41(5):903–18.
Article CAS PubMed Google Scholar
Ge W, Wang Y, Quan M, Mao T, Bischof EY, Xu H, Zhang X, Li S, Yue M, Ma J, Yang H, Wang L, Yu Z, Wang L, Jiujie Cui. Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular Glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib. Mol Cancer. 2024;23(1):48.
Article CAS PubMed PubMed Central Google Scholar
Zhu C, Xie Y, Li Q, Zhang Z, Chen J, Zhang K, Xia X, Yu D, Chen D, Zhengyuan Yu, and, Chen J. CPSF6-mediated XBP1 3’UTR shortening attenuates Cisplatin-Induced ER stress and elevates Chemo-Resistance in lung adenocarcinoma. Drug Resist Updates. 2023;68:100933.
Jiang M, Qi F, Zhang K, Zhang X, Ma J, Xia S, Chen L, Yu Z, Chen J, Chen D. MARCKSL1–2 reverses Docetaxel-Resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b. Mol Cancer. 2022;21(1):150.
Article CAS PubMed PubMed Central Google Scholar
Yang C, Deng X, Tang Y, Tang H. Chenglai Xia Nat Prod Reverse Cisplatin Resist Hypoxic Tumor Microenvironment Cancer Letters. 2024;598:217116.
Du R, Zhang X, Lu X, Ma X, Guo X, Shi C, Ren X, Ma X, He Y. Yuan gao, and Yunjiang liu. PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting Antibody-Dependent NK Cell-Mediated cytotoxicity. Drug Resist Updates. 2023;68:100947.
Fan G, Yu B, Tang L, Zhu R, Chen J, Zhu Y, Huang H, Zhou L, Liu J, Wang W, Tao Z, Zhang F, Yu S, Lu X, Cao Y, Du S, Li H, Li J, Zhang J, Ren H, Gires O, Liu H, Wang X, Qin J, Wang H. TSPAN8(+) myofibroblastic cancer-Associated fibroblasts promote chemoresistance in patients with breast cancer. Sci Transl Med. 2024;16:741.
Waks AG, Winer EP,. JAMA-journal Am Med Association. 2019;321(3):288–300.
Kalluri R, Valerie S. LeBleu. The Biology, Function, and Biomedical Applications of Exosomes. Science. 2020;367(6478).
Schmitt AM, Chang HY. Long Noncoding RNAs Cancer Pathways Cancer Cell. 2016;29(4):452–63.
Comments (0)